{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:15:44Z","timestamp":1791281744939,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/gt.2017.4","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T15:48:18Z","timestamp":1484236098000},"page":"215-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression"],"prefix":"10.1038","volume":"24","author":[{"given":"M L","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G C","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S B","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B G","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E H","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D P","family":"Vansteenkiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"BFgt20174_CR1","volume-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"SE Mole","year":"2011","unstructured":"Mole SE, Williams RE, Goebel HH . The Neuronal Ceroid Lipofuscinoses (Batten Disease), 2 edn. Oxford University Press: Oxford, UK, 2011."},{"key":"BFgt20174_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","volume":"1852","author":"SE Mole","year":"2015","unstructured":"Mole SE, Cotman SL . Gentics of the neuronal ceroid lipofuscinoses (Batten disease). Biochim Bipphys Acta 2015; 1852: 2237\u20132241.","journal-title":"Biochim Bipphys Acta"},{"key":"BFgt20174_CR3","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1086\/302427","volume":"64","author":"DE Sleat","year":"1999","unstructured":"Sleat DE, Gin RM, Sohar I, Wisniewski K, Sklower-Brooks S, Pullarkat RK et al. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. [Erratum appears in Am J Hum Genet. 2004 Dec;75(6):1158]. Am J Hum Genet 1999; 64: 1511\u20131523.","journal-title":"Am J Hum Genet"},{"key":"BFgt20174_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","volume":"89","author":"T Awano","year":"2006","unstructured":"Awano T, Katz ML, O'Brien DP, Sohar I, Lobel P, Coates JR et al. A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis. Mol Genet Metab 2006; 89: 254\u2013260.","journal-title":"Mol Genet Metab"},{"key":"BFgt20174_CR5","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1167\/iovs.08-1712","volume":"49","author":"ML Katz","year":"2008","unstructured":"Katz ML, Coates JR, Cooper JJ, O'Brien DP, Jeong M, Narfstrom K . Retinal pathology in a canine model of late infantile neuronal ceroid lipofuscinosis. Invest Ophthalmol Vis Sci 2008; 49: 2686\u20132695.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt20174_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/jnr.23423","volume":"92","author":"ML Katz","year":"2014","unstructured":"Katz ML, Coates JR, Sibigtroth CM, Taylor JD, Carpentier M, Young WM et al. Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease). J Neurosci Res 2014; 92: 1591\u20131598.","journal-title":"J Neurosci Res"},{"key":"BFgt20174_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1601-183X.2011.00718.x","volume":"10","author":"DN Sanders","year":"2011","unstructured":"Sanders DN, Kanazono S, Wininger FA, Whiting RE, Flournoy CA, Coates JR et al. A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosis. Genes Brain Behav 2011; 10: 798\u2013804.","journal-title":"Genes Brain Behav"},{"key":"BFgt20174_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.exer.2013.10.006","volume":"116","author":"RE Whiting","year":"2013","unstructured":"Whiting RE, Narfstrom K, Yao G, Pearce JW, Coates JR, Castaner LJ et al. Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis. Exp Eye Res 2013; 116: 402\u2013410.","journal-title":"Exp Eye Res"},{"key":"BFgt20174_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.exer.2015.02.012","volume":"134","author":"RE Whiting","year":"2015","unstructured":"Whiting RE, Pearce JW, Castaner LJ, Jensen CA, Katz RJ, Gilliam DH et al. Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis. Exp Eye Res 2015; 134: 123\u2013132.","journal-title":"Exp Eye Res"},{"key":"BFgt20174_CR10","doi-asserted-by":"publisher","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","volume":"7","author":"ML Katz","year":"2015","unstructured":"Katz ML, Tecedor L, Chen Y, Williamson BG, Lysenko E, Wininger FA et al. AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease. Sci Transl Med 2015; 7: 313ra180.","journal-title":"Sci Transl Med"},{"key":"BFgt20174_CR11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.bbadis.2012.11.014","volume":"1832","author":"GW Anderson","year":"2013","unstructured":"Anderson GW, Goebel HH, Simonati A . Human pathology in NCL. Biochim Biophys Acta 2013; 1832: 1807\u20131826.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt20174_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1006\/mgme.1999.2808","volume":"66","author":"HH Goebel","year":"1999","unstructured":"Goebel HH, Schochet SS, Jaynes M, Bruck W, Kohlschutter A, Hentati F . Progress in neuropathology of the neuronal ceroid lipofuscinoses. Mol Genet Metab 1999; 66: 367\u2013372.","journal-title":"Mol Genet Metab"},{"key":"BFgt20174_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/jnnp.38.10.985","volume":"38","author":"HH Goebel","year":"1975","unstructured":"Goebel HH, Zeman W, Pilz H . Significance of muscle biopsies in neuronal ceroid-lipofuscinoses. J Neurol Neurosurg Psychiatry 1975; 38: 985\u2013993.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFgt20174_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ajmg.1320570221","volume":"57","author":"BC Kieseier","year":"1995","unstructured":"Kieseier BC, Goebel HH . Immunelectronmicroscopic characterization of T4 and T8 lymphocytes and natural killer cells in neuronal ceroid-lipofuscinosis. Am J Med Genet 1995; 57: 222\u2013224.","journal-title":"Am J Med Genet"},{"key":"BFgt20174_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ymgme.2015.04.001","volume":"115","author":"D Gilliam","year":"2015","unstructured":"Gilliam D, Kolicheski A, Johnson GS, Mhlanga-Mutangadura T, Taylor JF, Schnabel RD et al. Golden Retriever dogs with neuronal ceroid lipofuscinosis have a two-base-pair deletion and frameshift in CLN5. Mol Genet Metab 2015; 115: 101\u2013109.","journal-title":"Mol Genet Metab"},{"key":"BFgt20174_CR16","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/jvim.13971","volume":"30","author":"A Kolicheski","year":"2016","unstructured":"Kolicheski A, Johnson GS, O\u2019Brien DP, Mhlanga-Mutangadura T, Gilliam D, Guo J et al. Australian Cattle Dogs with neuronal ceroid lipofuscinosis are homozygous for a CLN5 nonsense mutation previously identified in Border Collies. J Vet Intern Med 2016; 30: 1149\u20131158.","journal-title":"J Vet Intern Med"},{"key":"BFgt20174_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ymgme.2016.05.008","volume":"118","author":"A Ashwini","year":"2016","unstructured":"Ashwini A, D'Angelo A, Yamato O, Giordano C, Cagnotti G, Harcourt-Brown T et al. Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas. Mol Genet Metab 2016; 118: 326\u2013332.","journal-title":"Mol Genet Metab"},{"key":"BFgt20174_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ymgme.2014.05.014","volume":"112","author":"J Guo","year":"2014","unstructured":"Guo J, Johnson GS, Brown HA, Provencher ML, da Costa RC, Mhlanga-Mutangadura T et al. A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry. Mol Genet Metab 2014; 112: 302\u2013309.","journal-title":"Mol Genet Metab"},{"key":"BFgt20174_CR19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1212\/WNL.0b013e31821435bd","volume":"76","author":"JR Ostergaard","year":"2011","unstructured":"Ostergaard JR, Rasmussen TB, Molgaard H . Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology 2011; 76: 1245\u20131251.","journal-title":"Neurology"},{"key":"BFgt20174_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1469-8749.2011.04170.x","volume":"54","author":"S Fukumura","year":"2012","unstructured":"Fukumura S, Saito Y, Saito T, Komaki H, Nakagawa E, Sugai K et al. Progressive conduction defects and cardiac death in late infantile neuronal ceroid lipofuscinosis. Dev Med Child Neurol 2012; 54: 663\u2013666.","journal-title":"Dev Med Child Neurol"},{"key":"BFgt20174_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/ejpn.2000.0465","volume":"5","author":"IL Hofman","year":"2001","unstructured":"Hofman IL, van der Wal AC, Dingemans KP, Becker AE . Cardiac pathology in neuronal ceroid lipofuscinoses\u2014a clinicopathologic correlation in three patients. Europ J Paediatr Neurol 2001; 5: 213\u2013217.","journal-title":"Europ J Paediatr Neurol"},{"key":"BFgt20174_CR22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.2169\/internalmedicine.34.1158","volume":"34","author":"K Sakajiri","year":"1995","unstructured":"Sakajiri K, Matsubara N, Nakajima T, Fukuhara N, Makifuchi T, Wakabayashi M et al. A family with adult type ceroid lipofuscinosis (Kufs' disease) and heart muscle disease: report of two autopsy cases. Intern Med 1995; 34: 1158\u20131163.","journal-title":"Intern Med"},{"key":"BFgt20174_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1939-1676.2006.tb00712.x","volume":"20","author":"DB Adin","year":"2006","unstructured":"Adin DB, Oyama MA, Sleeper MM, Milner RJ . Comparison of canine cardiac troponin I concentrations as determined by 3 analyzers. J Vet Intern Med 2006; 20: 1136\u20131142.","journal-title":"J Vet Intern Med"},{"key":"BFgt20174_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1939-1676.2004.tb02629.x","volume":"18","author":"MA Oyama","year":"2004","unstructured":"Oyama MA, Sisson DD . Cardiac troponin-I concentration in dogs with cardiac disease. J Vet Intern Med 2004; 18: 831\u2013839.","journal-title":"J Vet Intern Med"},{"key":"BFgt20174_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ymgme.2011.06.018","volume":"104","author":"BR Vuillemenot","year":"2011","unstructured":"Vuillemenot BR, Katz ML, Coates JR, Kennedy D, Tiger P, Kanazono S et al. Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis. Mol Genet Metab 2011; 104: 325\u2013337.","journal-title":"Mol Genet Metab"},{"key":"BFgt20174_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ymgme.2014.09.004","volume":"114","author":"BR Vuillemenot","year":"2015","unstructured":"Vuillemenot BR, Kennedy D, Cooper JD, Wong AM, Sri S, Doeleman T et al. Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis. Mol Genet Metab 2015; 114: 281\u2013293.","journal-title":"Mol Genet Metab"},{"key":"BFgt20174_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.exer.2016.03.023","volume":"146","author":"REH Whiting","year":"2016","unstructured":"Whiting REH, Jensen CA, Pearce JW, Castaner LJ, Gillespie LE, Bristow DE et al. Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease. Exp Eye Res 2016; 146: 276\u2013282.","journal-title":"Exp Eye Res"},{"key":"BFgt20174_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0022-2828(86)80986-5","volume":"18","author":"D Armstrong","year":"1986","unstructured":"Armstrong D, Lombard C, Ellis A . Electrocardiographic and histologic abnormalities in canine ceroid-lipofuscinosis (CCL). J Mol Cell Cardiol 1986; 18: 91\u201397.","journal-title":"J Mol Cell Cardiol"},{"key":"BFgt20174_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000115699","volume":"23","author":"P Michielsen","year":"1984","unstructured":"Michielsen P, Martin JJ, Vanagt E, Vrints C, Gillebert T, Snoeck J . Cardiac involvement in juvenile ceroid lipofuscinosis of the Spielmeyer-Vogt-Sjogren type: prospective noninvasive findings in two siblings. Eur Neurol 1984; 23: 166\u2013172.","journal-title":"Eur Neurol"},{"key":"BFgt20174_CR30","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10545-014-9718-3","volume":"37","author":"CE Hollak","year":"2014","unstructured":"Hollak CE, Wijburg FA . Treatment of lysosomal storage disorders: successes and challenges. J Inherit Metab Dis 2014; 37: 587\u2013598.","journal-title":"J Inherit Metab Dis"},{"key":"BFgt20174_CR31","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.lpm.2013.12.022","volume":"43","author":"P Kaminsky","year":"2014","unstructured":"Kaminsky P, Lidove O . Current therapeutic strategies in lysosomal disorders. Presse Med 2014; 43: 1174\u20131184.","journal-title":"Presse Med"},{"key":"BFgt20174_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/jcpt.12136","volume":"39","author":"H Noh","year":"2014","unstructured":"Noh H, Lee JI . Current and potential therapeutic strategies for mucopolysaccharidoses. J Clin Pharm Ther 2014; 39: 215\u2013224.","journal-title":"J Clin Pharm Ther"},{"key":"BFgt20174_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/1872214808666140115111350","volume":"8","author":"S Ortolano","year":"2014","unstructured":"Ortolano S, Vieitez I, Navarro C, Spuch C . Treatment of lysosomal storage diseases: recent patents and future strategies. Recent Pat Endocr Metab Immune Drug Discov 2014; 8: 9\u201325.","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"BFgt20174_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-4939-3112-5_21","volume":"1364","author":"BD Dufour","year":"2016","unstructured":"Dufour BD, McBride JL . Intravascular AAV9 administration for delivering RNA silencing constructs to the CNS and periphery. Methods Mol Biol 2016; 1364: 261\u2013275.","journal-title":"Methods Mol Biol"},{"key":"BFgt20174_CR35","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/mt.2015.6","volume":"23","author":"Y Gong","year":"2015","unstructured":"Gong Y, Mu D, Prabhakar S, Moser A, Musolino P, Ren J et al. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy. Mol Ther 2015; 23: 824\u2013834.","journal-title":"Mol Ther"},{"key":"BFgt20174_CR36","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1096\/fj.14-269092","volume":"29","author":"CN Mattar","year":"2015","unstructured":"Mattar CN, Wong AM, Hoefer K, Alonso-Ferrero ME, Buckley SM, Howe SJ et al. Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates. Faseb J 2015; 29: 3876\u20133888.","journal-title":"Faseb J"},{"key":"BFgt20174_CR37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/mt.2014.240","volume":"23","author":"JS Walia","year":"2015","unstructured":"Walia JS, Altaleb N, Bello A, Kruck C, LaFave MC, Varshney GK et al. Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates. Mol Ther 2015; 23: 414\u2013422.","journal-title":"Mol Ther"},{"key":"BFgt20174_CR38","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1093\/hmg\/ddv168","volume":"24","author":"CM Weismann","year":"2015","unstructured":"Weismann CM, Ferreira J, Keeler AM, Su Q, Qui L, Shaffer SA et al. Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan. Hum Mol Genet 2015; 24: 4353\u20134364.","journal-title":"Hum Mol Genet"},{"key":"BFgt20174_CR39","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1939-1676.2001.tb01582.x","volume":"15","author":"MM Sleeper","year":"2001","unstructured":"Sleeper MM, Clifford CA, Laster LL . Cardiac troponin I in the normal dog and cat. J Vet Intern Med 2001; 15: 501\u2013503.","journal-title":"J Vet Intern Med"},{"key":"BFgt20174_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1939-1676.2009.0428.x","volume":"24","author":"I Ljungvall","year":"2010","unstructured":"Ljungvall I, Hoglund K, Tidholm A, Olsen LH, Borgarelli M, Venge P et al. Cardiac troponin I is associated with severity of myxomatous mitral valve disease, age, and C-reactive protein in dogs. J Vet Intern Med 2010; 24: 153\u2013159.","journal-title":"J Vet Intern Med"},{"key":"BFgt20174_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/B978-0-12-370491-7.00012-X","volume-title":"Clinical Biochemistry of Domestic Animals","author":"WE Hoffmann","year":"2008","unstructured":"Hoffmann WE, Solter PF . Diagnostic enzymology of domestic animals. In: Koneko JJ, Harvey JW, Bruss ML (eds). Clinical Biochemistry of Domestic Animals, 6 edn. Elsevier: Oxford, UK, 2008, pp 351\u2013378."},{"key":"BFgt20174_CR42","first-page":"735","volume-title":"Tietz Textbook of Clinical Chemistry","author":"DW Moss","year":"1994","unstructured":"Moss DW, Henderson AR . Enzymes. In: Burtis CA, Ashwood ER (eds). Tietz Textbook of Clinical Chemistry, 2 edn. WB Saunders: Philidelphia, PA, USA, 1994, pp 735\u2013896."},{"key":"BFgt20174_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF01839386","volume":"17","author":"M Aktas","year":"1993","unstructured":"Aktas M, Auguste D, Lefebvre HP, Toutain PL, Braun JP . Creatine kinase in the dog: a review. Vet Res Commun 1993; 17: 353\u2013369.","journal-title":"Vet Res Commun"},{"key":"BFgt20174_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","volume":"7","author":"WP Thomas","year":"1993","unstructured":"Thomas WP, Gaber CE, Jacobs GJ, Kaplan PM, Lombard CW, Moise NS et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 1993; 7: 247\u2013252.","journal-title":"J Vet Intern Med"},{"key":"BFgt20174_CR45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2460\/javma.1982.181.01.46","volume":"181","author":"WE Wingfield","year":"1982","unstructured":"Wingfield WE, Boon J, Miller CW . Echocardiographic assessment of mitral valve motion, cardiac structures, and ventricular function in dogs with atrial fibrillation. J Am Vet Med Assoc 1982; 181: 46\u201349.","journal-title":"J Am Vet Med Assoc"},{"key":"BFgt20174_CR46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1939-1676.2000.tb02252.x","volume":"14","author":"M Rishniw","year":"2000","unstructured":"Rishniw M, Erb HN . Evaluation of four 2-dimensional echocardiographic methods of assessing left atrial size in dogs. J Vet Intern Med 2000; 14: 429\u2013435.","journal-title":"J Vet Intern Med"},{"key":"BFgt20174_CR47","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1939-1676.2010.0575.x","volume":"24","author":"G Wess","year":"2010","unstructured":"Wess G, Maurer J, Simak J, Hartmann K . Use of Simpson's method of disc to detect early echocardiographic changes in Doberman Pinschers with dilated cardiomyopathy. J Vet Intern Med 2010; 24: 1069\u20131076.","journal-title":"J Vet Intern Med"},{"key":"BFgt20174_CR48","first-page":"153","volume-title":"Veterinary Echcardiography","author":"J Boon","year":"2011","unstructured":"Boon J . Evaluation of size, function and hemodynamics. In: Boon J (ed). Veterinary Echcardiography, 2 edn. Wiley-Blackwell: Oxford, UK, 2011, pp 153\u2013166."},{"key":"BFgt20174_CR49","first-page":"905","volume":"5","author":"JR Turk","year":"1983","unstructured":"Turk JR, Root CR . Necropsy of the canine heart: a simple technique for quantifying ventricular hypertrophy and valvular alterations. Compend Contin Educ Pract Vet 1983; 5: 905\u2013910.","journal-title":"Compend Contin Educ Pract Vet"},{"key":"BFgt20174_CR50","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/(SICI)1097-4547(19990701)57:1<106::AID-JNR11>3.0.CO;2-Z","volume":"57","author":"ML Katz","year":"1999","unstructured":"Katz ML, Gao CL, Rice LM . Long-term variations in cyclic light intensity and dietary vitamin A intake modulate lipofuscin content of the retinal pigment epithelium. J Neurosci Res 1999; 57: 106\u2013116.","journal-title":"J Neurosci Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/gt20174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gt20174","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gt20174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:46:35Z","timestamp":1749897995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt20174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFgt20174"],"URL":"https:\/\/doi.org\/10.1038\/gt.2017.4","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]},"assertion":[{"value":"19 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}